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Abstract 
A ' proportional ctivation' approach designed to deal with the influence of external effectors within biochemical systems i described. 
The proportional activation coefficient, which enables the quantitative determination of the relative stimulation of different parts of a 
system by a given effector, is defined. The proportional ctivation approach was used to calculate the relative activation of Ap-producing 
and Ap-consuming subsystems during stimulation of the respiration rate of cells by a variety of different effectors. Oxidative 
phosphorylation was stimulated by the addition of either lactate and pyruvate (10 mM and 1 mM) or vasopressin. The addition of lactate 
and pyruvate to suspensions of resting hepatocytes increased the respiration rate by about 50%. The Ap-consuming subsystem was 
stimulated about 60% as much as the Ap-producing subsystem. Quinolinic acid, commonly considered to be a specific inhibitor of 
gluconeogenesis, was found to block the Ap-producing oxidative subsystem as well as the Ap-consuming subsystem, indicating some 
nonspecific effects of this inhibitor. Addition of vasopressin to hepatocytes that were incubated in the presence of lactate and pyruvate 
resulted in an increase of the respiratory rate by up to 35%. The relative stimulation of the Ap-producing and Ap-consuming subsystems 
was essentially equal. Using the 'proportional ctivation approach' to analyse these and previously published data, it is shown that 
substrates (lactate/pyruvate nd fatty acids), Ca2+-acting hormones (vasopressin and others) and calcium in muscles (heart muscle and 
skeletal muscle) activate both subsystems to a similar extent (it concerns especially Ca2+-dependent systems). 
Keywords: Oxidative phosphorylation; Proportional ctivation; Calcium-acting hormone; Gluconeogenesis; Lactate; Pyruvate 
1. Introduct ion 
The oxidative phosphorylation system can be divided 
into two subsystems: a Ap-producing subsystem contain- 
ing oxidation subsystem (substrate transport, substrate de- 
hydrogenation, respiratory chain), and a Ap-consuming 
subsystem containing a phosphorylation subsystem (ATP 
synthase, ATP/ADP carrier, phosphate carrier, ATP us- 
age) and proton leak. Two opposing opinions concerning 
activation of oxidative phosphorylation by external effec- 
tors (hormones and neural stimulation of muscle) exist in 
Abbreviations: Ap, protonmotive force; A~m, mitochondrial mem- 
brane potential; TPMP +, triphenylmethylphosphonium; OX, oxidation 
subsystem; PH, phosphorylation subsystem; LK, proton leak subsystem; 
PH + LK, phosphorylation + proton leak subsystem; coefficients; E, elas- 
ticity coefficient; K, special elasticity coefficient ( o external effector); P, 
proportional ctivation coefficient. 
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the literature. According to the first opinion, one of the 
aforementioned subsystems i  stimulated irectly, the other 
being stimulated by an increase (decrease) in Ap (and 
other relevant parameters, asATP/ADP or NADH/NAD). 
The second opinion is that both subsystems are activated. 
It has, for example, been proposed [1-3] that calcium- 
stimulated ATP utilisation during muscular contraction 
leads to increases in ADP concentration and decreases in 
the phosphorylation potential. This, in turn, activates the 
oxidation subsystem to the extent necessary to maintain 
sufficient ATP concentration. Similarly, it was proposed 
that Ca2+-acting hormones (such as vasopressin, adrenaline 
and glucagon) exclusively activated the substrate dehydro- 
genation subsystem (i.e., that part of the oxidation system 
which includes glycolysis, Krebs cycle and fatty acid 
fl-oxidation) resulting in an increased ATP/ADP ratio and 
the stimulation of cellular processes (such as gluconeo- 
genesis) that are sensitive to this ratio [4]. On the other 
hand, some other authors discuss a parallel activation of 
different subsystems [5-10]. However, such models are 
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only intuitive and qualitative. This is clearly seen when we 
compare the 'latent enzymes' [11] and the 'multi-site 
activation' [12,13] ideas. Starting from the same fact of 
small changes in the ATP/ADP ratio during muscle con- 
traction, the first hypothesis ays that the PH( + LK) sub- 
system is activated exclusively and the sensitivity of the 
OX subsystem to ATP/ADP is great and the second one 
says that both the OX and PH + LK subsystems are acti- 
vated to a similar extent. 'Small changes' says nothing 
until they are compared with kinetic responses to interme- 
diate metabolite concentration of the OX and PH + LK 
subsystems. Opinions in the recent literature still exist 
supporting both the opposing ideas [2-4,11] vs. [8,12,13]. 
In some studies it was shown that both subsystems were 
activated, but the relative extent of this stimulation has not 
been estimated. Therefore, a more quantitative, ven crude 
method seems to be advantageous. 
Lactate and pyruvate (10 mM and 1 mM respectively) 
are commonly added to incubation media for hepatocytes. 
This leads to an increase in the respiration rate. It is 
thought that lactate + pyruvate activate gluconeogenesis 
[18]. It would be interesting to check whether these sub- 
strates timulate also Ap-producing processes. 
Ouinolinic acid, through its effect on phospho enolpyru- 
vate carboxykinase, is thought o be a specific inhibitor of 
gluconeogenesis [20]. However, the specificity of its in- 
hibitory action has not been rigorously assessed. There- 
fore, it would be important to determine whether there are 
nonspecific effects of this inhibitor on the oxidative phos- 
phorylation system (i.e., beyond the expected inhibition of 
the phosphorylation + proton leak subsystem). 
The proportional activation of the zip-producing and 
zip-consuming subsystems by CaZ+-acting hormones, like 
vasopressin, glucagon and adrenaline is also interesting. 
Ca2+-acting hormones have been shown to stimulate the 
respiration rate, increase the mitochondrial ATP/ADP [21] 
and NADH/NAD + [22] ratios and increase the cy- 
tochrome c reduction level [22]. The simplest interpreta- 
tion of these findings is that the oxidative subsystem is 
activated [4,16]. This opinion is supported in Ref. [19]. On 
the other hand, quantitative calculations using a dynamic 
mathematical model of oxidative phosphorylation [15] sug- 
gest that both subsystems are activated to a very similar 
extent. Therefore, the problem requires additional studies. 
The purpose of the work described here was to use the 
proposed method, the proportional activation approach, to 
identify the important sites of action (and to determine the 
relative extent of the effects at these sites) of lactate plus 
pyruvate, of the gluconeogenic nhibitor, quinolinate, and 
of vasopressin on oxidative phosphorylation. 
2. Proportional activation approach 
Let us consider the simple biochemical system pre- 
sented in Fig. la. The concentration of its substrate S and 
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Fig. 1. (a) The system. S, substrate, P  product, M, intermediate metabo- 
lite, A, M-producing subsystem, B, M-consuming subsystem, J  flux 
through the system, X, external effector. X affects the system as a 'black 
box', causing a net increase in the flux J through the system. (b) X 
activates subsystem A directly and exclusively. Subsystem B is activated 
by the increase in M concentration. (c) X activates subsystems A and B to 
a similar extent. [M] remains approximately the same. 
product P is kept constant. The system is divided into two 
subsystems: subsystem A, producing an intermediate 
metabolite, M, and subsystem B, consuming this metabo- 
lite. Let us assume that these subsystems affect each other 
only through changes in the concentration of M. The 
system is activated by an external effector, X, leading to a 
net increase of flux, J, through the system. At the begin- 
ning the system is treated as a 'black box' (Fig. la), as the 
mechanism of the activation is unknown. 
There are two possible extreme cases. The first is 
presented in Fig. lb. In this case the external effector 
stimulates ubsystem A exclusively and directly; the in- 
crease in flux through B is solely a consequence of an 
increase in the concentration of the common metabolite M. 
Similarly, we could consider the case where the external 
effector stimulates B, and the increase in flux through A 
is due to a decrease in M. 
In the second case, the external effector X stimulates 
both subsystems A and B to a similar extent, such that M 
remains approximately constant (Fig. lc). 
The relevant question for a given effector in the cell is 
whether this effector acts on only one side of M, or there is 
equal activation on each side of M, or whether a case in 
between these two extremes occurs. 
Titration of both subsystems with specific inhibitors and 
simultaneous measurements of changes in flux J intensity 
and intermediate metabolite M concentration enables the 
determination of elasticity coefficients of subsystems A
and B to the common metabolite M at a steady-state point 
under physiological conditions. If the titration curves are 
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Fig. 2. Changes in flux J intensity and metabolite M concentration after 
external effector X addition, representing transition from the old steady 
state (full square) to a new one (open square). The lines representing the 
kinetic responses (in the 'linear' case corresponding to elasticity coeffi- 
cients) of subsystems A and B to metabolite M are also shown. This set 
of data is the basis for calculation of the P coefficient. 
linear (or nearly linear), the elasticity coefficient values 
can be extrapolated for a broader ange of conditions, and 
finite changes (A) instead of infinitesimal ones (d) can be 
considered. Such near-linear titration curves were ob- 
tained, when the 'top-down' approach to Metabolic Con- 
trol Analysis [25] was used with intact hepatocytes, for 
Ap-producing reactions (OX subsystem) and Ap-consum- 
ing reactions (PH + LK subsystem) [17,19,23,24]. In a 
simplified oxidative phosphorylation system, A is the OX 
subsystem following the scheme shown in Fig. la, B is the 
PH + LK subsystem, M is Ap (or A~ m), J is the respira- 
tion rate and X may be Ca 2+, a hormone, a substrate or 
some other external effector. 
After the introduction of an external effector to the 
system, a new steady state will be achieved with a changed 
flux J and a changed common metabolite M concentration 
(Fig. 2). What we are interested in is: activation of B 
divided by activation of A. A parameter which we will 
refer to as the proportional activation coefficient, which 
describes this ratio, is mathematically defined as follows: 
p~B = ~ dA/A  Ix (1) 
where A and B are activities of subsystems A and B. In 
other words, the proportional activation coefficient is the 
infinitesimal relative change in the subsystem B activity 
caused by external effector X divided by such a change in 
the subsystem A activity. 
It is necessary to relate this coefficient o the elasticity 
coefficients of subsystems A and B to common metabolite 
M and to changes in this metabolite concentration and flux 
J intensity after external effector X addition (see Fig. 2). 
The slope of the line representing the effector action ~- can 
be defined as follows: 
dM/M 
r (2) 
d J / J  
where M is metabolite M concentration and J is flux J 
intensity. The relative change in flux J intensity, caused 
by relative changes in activity of subsystem B is equal to: 
(dJ/ J)B = eM B" (dM/M)  + K B" (dX/X)  (3) 
where • indicates elasticity coefficient to internal metabo- 
lite and K indicates pecial elasticity coefficient to external 
effector, respectively. An analogous equation can be writ- 
ten for subsystem A. Dividing one equation by the other 
we obtain, taking into account hat, for a given concentra- 
tion of X, B A Kx/K  x = (dB/B) / (dA/A) ,  the following ex- 
pression: 
1 -•~- r  
Px An (4) 
1--•MA,~ - 
Eq. (4) exhibits some interesting properties: 
1. If there is no change in intermediate metabolite M 
concentration after external effector addition (~" = 0), then 
the proportional activation coefficient is equal to unity 
(P  = 1). This case occurs when both subsystems A and B 
are activated to exactly the same extent. 
2. If 7= 1/eM s , then only subsystem A is activated and 
P = 0. Alternatively, if 7 = 1/•M A, then only B is activated 
and P = infinity (the last property is maybe not very 
convenient but it is easy to interpret). Therefore, eU h and 
• u B fix the range of possible ~- values (see below for a 
discussion of the situation where neither subsystem is 
inhibited by a given external effector). 
3. The proportional activation approach applies to in- 
hibitors of biochemical pathways as well. For example, it 
allows the estimation of the relative inhibition of Ap-pro- 
ducing and Ap-consuming reactions by a given inhibitor. 
4. If the value of the P coefficient is negative, it means 
that one of the subsystems i activated and the other is 
inhibited by a given external effector. 
5. If the absolute value of the elasticity coefficient of 
one subsystem is significantly greater than the absolute 
value of the elasticity coefficient of the other subsystem, 
then the former coefficient will be mainly responsible for 
the deviation of the P coefficient from unity. 
The proportional activation approach is valid for the 
oxidative phosphorylation system only under some as- 
sumptions: 
1. Ap is the only 'connection' between the Ap-produc- 
ing and Ap-consuming subsystem. This has been shown 
for hepatocytes [19]. However for, for example, muscle it 
can be only an approximation. However, such an approxi- 
mation is supported by the fact that Krebs cycle in muscle 
is only weakly dependent on the ATP/ADP ratio, being 
predominantly regulated by the NADH/NAD + ratio [26]. 
2. An external effector does not affect significantly the 
elasticities of the both considered subsystems to Ap. How- 
ever, this assumption is not important when we consider 
infinitesimal changes in the flux intensity and M concen- 
tration. 
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3. The kinetic responses of the OX and PH+ LK 
subsystems to Ap are near linear. This was shown for 
hepatocytes in a broad range of the respiration rate and Zip 
[17,19], but for other conditions and cells it can be only an 
approximation. 
4. The kinetic responses of the both considered subsys- 
tems to Ap do not change significantly from experiment to 
experiment. As different experiments are performed under 
slightly different conditions, it can be true only approxi- 
mately. 
Because of these limitations, the proportional activation 
approach is surely crude. However, even a semiquantita- 
rive method seems to be an advance in relation to purely 
intuitive considerations. 
(S.E.M., n = 18) nmol O2/min per mg dry weight. The 
average plasma membrane potential (assessed using distri- 
bution of 36C1) was 32.3 ___ 13.5 (S.E.M., n = 5) mV and 
the average A1/f m was  173.4 _ 14.1 (S.E.M., n = 5) mV. 
The values for the respiration rate and mitochondrial mem- 
brane potential were slightly greater than those obtained in 
[17]; perhaps this is due to a slightly higher cell viability in 
the present study than in the earlier study. The average 
respiration rate for hepatocytes that were incubated in the 
absence of lactate and pyruvate, and isolated from younger 
rats (up to 300 g, see below), was 4 .42_  0.20 (S.E.M., 
n = 6) nmol Oz/min per mg dry weight. These values 
were used as the 100% values in all of the following 
results. There were no changes in plasma membrane poten- 
tial under any of the incubation conditions used. 
3. Materials and methods 4.2. Effect of  lactate and pyruvate 
The experimental procedures used, including the prepa- 
ration and incubation of rat hepatocytes and measurements 
of respiration rate and A1/¢ m were  as described by Harper 
and Brand [17]. Hepatocytes were prepared from fed male 
Wistar rats (240-400 g). The viability of cells as assessed 
by the exclusion of Trypan blue (0.3 w/v )  was greater 
than 96%. Cellular respiration rates were measured at 
37 ° C in duplicate, using two Clark-type oxygen elec- 
trodes. Non-mitochondrial oxygen consumption was iden- 
tified as the oxygen consumption that was insensitive to 1 
/xM myxothiazol and was subtracted from respiration rates. 
A1/-r m was  calculated from the distribution of TPMP with 
corrections for plasma membrane potential, cytoplasmic 
and mitochondrial binding of TPMP and other factors, as 
described in [17]. 
The elasticity coefficients to A~ m for hepatocytes incu- 
bated without lactate and pyruvate are about ea,~°x = _ 7 
and {A~ mPH +LK = 3 (assessed in [19]); those determined in the 
presence of lactate/pyruvate are about eA,mOX = _ 11 and 
PH +LK 7 (assessed in [17]). a~Fm ---- 
4. Results and discussion 
4.1. Average absolute values of  measured parameters 
Because absolute values of such parameters as the 
respiration rate, mitochondrial membrane potential (zi~m) 
and plasma membrane potential (A~ c) differed somewhat 
between different preparations, in the following discussion 
we deal with relative values and changes. Moreover, for 
the 'proportional ctivation' approach only relative changes 
in parameter values are needed. However, the absolute 
values which were used as the 100% values (i.e., 0% 
change) which are shown in Figs. 3, 4 and 6 are given 
below. 
The average respiration rate of hepatocytes incubated in 
the presence of lactate and pyruvate was 6 .18_  0.15 
The addition of 10 mM lactate and 1 mM pyruvate to 
the incubation medium resulted in an increase of the 
respiration rate by about 50% in hepatocytes i olated from 
younger ats (up to 300 g). The stimulation of respiration 
in hepatocytes from older rats (more than 300 g) was about 
10-25%. The difference could be due to differences in 
hepatic gluconeogenic apacities between younger and 
older rats. Because the changes in respiration rate were 
higher and more repeatable in hepatocytes from younger 
rats compared with older rats all subsequent experiments 
involved cells from younger ats. The relative changes in 
Ai/z m plotted against he relative changes in the respiration 
rate following the addition of lactate and pyruvate are 
presented in Fig. 3. It can be seen that changes in mito- 
chondrial membrane potential are small. The calculated 
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Fig. 3. Effect of lactate and pyruvate on oxidative phosphorylation. 
Changes in mitochondrial membrane potential (A~ m) are compared with 
changes in the respiration rate after the addition of lactate/pyruvate. 
Points are from six measurements. Each A~ m determination was carried 
out in triplicate and each respiration rate determination was carried out 
simultaneously in duplicate. The 100% values (i.e., 0% change) were 
determined for hepatocytes incubated in the absence of lactate and 
pyruvate. 
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value of proportional activation coefficient (0.64) indicates 
that the addition of lactate and pyruvate activates the 
phosphorylation + proton leak subsystem by about 2 /3  of 
the extent o which it stimulates the oxidation subsystem. 
Which parts of these subsystems are likely to be stimu- 
lated? Among the Ap-consuming reactions, gluconeo- 
genesis is the main candidate, since pyruvate is a substrate 
for the pathway. Mercaptopicolinic acid and quinolinic 
acid, considered as inhibitors of gluconeogenesis, removed 
almost all the stimulation of respiration rate by lactate and 
pyruvate. This supports the idea that lactate and pyruvate 
directly stimulate gluconeogenesis. However, as described 
below, quinolinic acid does not appear to be a specific 
inhibitor of gluconeogenesis. The stimulation of Ap pro- 
duction is likely to be via the provision of NADH. 
4.3. Effect of fatty acids 
The 'proportional ctivation' approach can be also used 
to analyse previously published results. Nobes et al. [27] 
showed that the addition of fatty acids to hepatocytes 
(incubated without lactate and pyruvate) increased the 
respiration rate by 92%, while Agt m changed by 7 mV 
(from 155 to 162 mV). The calculated value of the propor- 
tional activation coefficient is P = 0.63. As for the stimu- 
lation resulting from the addition of lactate and pyrnvate, 
the stimulation of the Ap-consuming subsystem was about 
2 /3  of that of the Ap-producing subsystem. The activa- 
tion of the phosphorylation subsystem could reflect in- 
creased lipogenesis or triacylglycerol formation or cycles 
in fat metabolism among other effects. It has been shown 
[27] that there is no uncoupling of oxidative phosphoryla- 
tion by fatty acids, so the proton leak is not affected. The 
stimulation of the oxidation subsystem could be due to 
increased reducing equivalent supply. 
4.4. Effect of quinolinic acid 
Quinolinic acid is known as an inhibitor of gluconeo- 
genesis. Our results show that it eliminates the activation 
by lactate/pyruvate of respiration rate at a concentration 
of 2 mM. However, at higher concentrations it blocked 
respiration even more than could be expected from inhibit- 
ing gluconeogenesis exclusively. To determine whether 
quinolinic acid inhibited the oxidation subsystem (includ- 
ing substrate transport, substrate dehydrogenation a d res- 
piratory chain) as well as the phosphorylation + proton 
leak subsystem, we measured changes in the respiratory 
rate and A~ m after the addition of a moderate concentra- 
tion of quinolinic acid (2 mM) to hepatocytes incubated 
with lactate and pyruvate. The results obtained are shown 
in Fig. 4. The inhibitor caused a decrease in the respiration 
rate by 15-30%. A1/t m also decreased, dearly indicating 
that the Ap-producing reactions were inhibited even more 
than the Ap-consuming reactions. The value of the P 
coefficient (0.51) indicates that the inhibition of the oxida- 
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Fig. 4. Changes inmitochondrial membrane potential (Aft' m) compared to
changes inrespiration rate after the addition of quinolinic acid. The points 
represent mean values of four measurements from two cell preparations 
and a single measurement from third cell preparation. The 100% values 
(i.e., 0% change) were determined for hepatocytes incubated in the 
presence oflactate and pyruvate. 
tion subsystem was approximately twice that of the phos- 
phorylation + proton leak subsystem. Therefore, quinolinic 
acid is not a specific inhibitor of gluconeogenesis. Never- 
theless, it caused quite significant inhibition of the alp- 
consuming subsystem, suggesting a decrease in gluco- 
neogenic flux. Thus the 'proportional ctivation' approach 
is a simple and useful method for testing inhibitor speci- 
ficity in complex systems. 
4.5. Effect of vasopressin 
Both the preincubation of hepatocytes with vasopressin 
(25 nM) in the presence of lactate and pyruvate and the 
addition of vasopressin to the oxygen electrode chamber 
during measurements resulted in increases in the respira- 
tory rate by 10-35%. This activation exhibited a plateau 
for about 20 min and then respiration returned slowly to its 
initial rate (Fig. 5). The decreased stimulation over time 
130 
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Fig. 5. Time-course of the activation ofrespiration rate after the addition 
of vasopressin. Data are from 13 independent preparations. The error bars 
represent s andard errors of the means. 100% of the respiratory ate is 
relative to values from hepatocytes incubated in the presence of 
lactate/pyruvate ndin the absence ofvasopressin. 
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may be explained by down-regulation of receptors [28]. 
There were no changes over the same length of time in the 
respiration rate of control hepatocytes. The time necessary 
for TPMP equilibration across the mitochondrial inner 
membrane and other membranes was equal to 10-15 min 
in presence of vasopressin. Therefore all measurements 
were performed 15 min or later after the addition of 
vasopressin (about 2 /3  of them were made after 15 min 
and the remainder were made after 20-60 min). Plasma 
membrane potential and cellular volume did not change 
after the addition of vasopressin. Mitochondrial volume 
was assumed to be constant. Some changes in mitochon- 
drial volume after vasopressin addition have been mea- 
sured previously [29], using a different incubation medium. 
However, we found that TPMP distribution was extremely 
stable after vasopressin addition and it is highly improba- 
ble that A~ m decreased exactly to the extent necessary to 
compensate for changes in mitochondrial volume to keep 
the TPMP gradient constant. If the changes in volume 
reported in [29] are correct hen we would obtain results 
which supported the conclusion that the phosphorylation 
subsystem was activated by vasopressin significantly more 
than the oxidation subsystem (see below). This would 
contradict he results of several studies of the effect of 
Ca2+-acting hormones [19,21,22]; all of these studies how 
a greater activation of the oxidation subsystem than the 
phosphorylation + proton leak subsystem. 
Fig. 6 presents the effects of the addition of vasopressin 
on mitochondrial membrane potential and on respiration 
rate. No changes in AaFrn were observed after the addition 
of vasopressin, while respiration rate increased by up to 
35%. This indicates that the Ap-producing and Ap-con- 
suming reactions were activated to similar extents. This 
result is in agreement with the earlier finding [30] that 
glucagon, another Ca 2+ (and cAMP)-acting hormone [4], 
caused no change in ApH. The P coefficient of 1.10 
quantifies this conclusion of the almost equal activation by 
vasopressin of both the subsystems in cells that are incu- 
bated in the presence of lactate and pyruvate. The main 
Ap-consuming process affected by Ca 2+ is probably 
gluconeogenesis. The ATP/ADP carrier is probably also 
activated [15,31]. Within the Ap-producing subsystem the 
most probable and well-characterized targets are the cal- 
cium-sensitive Krebs cycle dehydrogenases [32]. 
Brown et al. [19] found that the addition of vasopressin 
resulted, almost exclusively, in the stimulation of the 
NADH-producing subsystem. However, this experiment 
was performed on hepatocytes incubated without 
lactate/pyruvate; hus gluconeogenesis, probably the main 
target for calcium ions in the phosphorylation + proton 
leak subsystem, was absent. Furthermore, the results were 
different at 30 and 90 s after the addition of vasopressin, 
which implies that a steady state had not been achieved. 
This conclusion is supported by the fact that the transition 
time between different steady-states in the intact cell is 
estimated to be a few minutes [33]. 
The dynamic model of the oxidative phosphorylation 
system [14,15] predicted that the Ap-producing and Ap- 
consuming subsystems would be activated to approxi- 
mately equal extents after the addition of vasopressin. The 
results of this study support his prediction. The model also 
predicted that Ca 2+ would activate the ATP/ADP carder. 
Earlier studies have shown that calcium ions probably do 
stimulate this transporter, although other possibilities were 
also discussed [31]. Thus experimental findings do provide 
a support for at least the general properties of this model. 
4.6. Effect of glucagon 
It was found that glucagon, increasing the respiration 
rate, does not change ApH [30]. Therefore the proportional 
activation coefficient for this hormone is close to 1, within 
an experimental error. 
4. 7. Effect of Ca 2 +-acting hormones generally 
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Fig. 6. Changes in mitochondrial membrane potential (A~ m) during the 
stimulation of respiration rate by vasopressin. Each A1/t m determination 
was  carried out in triplicate and each respiration rate determination was 
carried out simultaneously in duplicate. Data are from 11 independent 
preparations. 
Using the dynamic model of oxidative phosphorylation 
[14,15], we assessed the value of the proportional activa- 
tion coefficient for the Ca2+-acting hormones as equal to 
about 0.8-1.0. The basis for calculations were reported in 
the literature [21,22] changes in the respiration rate, inter- 
nal ATP/ADP ratio as well as cytochrome c and the NAD 
reduction level. 
4.8. Effect of neural stimulation in muscle 
The kinetic response of the OX subsystem to Ap in 
heart muscle was assessed from changes in the respiration 
rate and the internal ATP/ADP ratio in heart mitochondria 
during State 4--* State 3 transition [26]. The kinetic re- 
sponse of the PH(+ LK) subsystem to Ap is most proba- 
bly much smaller [10] and therefore have little influence 
on the value of the proportional activation coefficient 
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Table 1 
Proportional activation coefficients for different external effeectors of 
oxidative phosphorylation 
External effector Proportional activation coefficient 
Lactate/pyruvate 0.5 -0.7 
Fatty acids 0.5-0.7 
Vasopressin 1.0-1.2 
Glucagon --- 1.0 
Ca2+-acting hormones generally 0.8-1.0 
Ca 2+ in heart muscle 1.0-1.1 
Ca 2+ in skeletal muscle 1.0-1.1 
Because the method used is rough, only approximate values are pre- 
sented. 
(compare Eq. (4)). Rough calculations of proportional 
activation coefficients using changes in the respiration rate 
and ATP/ADP ratio during muscle contraction [34,35] 
gave 1.06 for heart muscle and 1.07 for skeletal muscle. 
The values obtained are very close to each other and very 
close to unity. 
4.9. General conclusions 
The 'proportional activation' approach described here 
allows the estimation of the relative stimulation (or inhibi- 
tion) by an external effector of processes that produce and 
consume a common intermediate. The method is simple, 
quick, although crude, and needs very little experimental 
data if control elasticity values are already available. If 
these values are not available, or when more detailed 
information is required for the quantitative identification of 
the sites of action of external effectors, top-down elasticity 
analysis [36,37] is more appropriate. On the other hand, the 
proportional activation approach allows the estimation of 
the importance of blocks of reactions when the flux through 
the system is altered by an external effector and when the 
available xperimental techniques preclude a full top-down 
elasticity analysis (e.g., identification of the sites of action 
of neural signals in muscle). It must be taken into account 
that the method is crude, as discussed above, and therefore 
the values of the P coefficient are only approximate ones. 
However, this does not change our general conclusions. 
The results described in this paper arise from the appli- 
cation of the proportional ctivation approach to the oxida- 
tive phosphorylation system comprised of the Ap-produc- 
ing (i.e., substrate oxidation) and Ap-consuming (i.e., 
proton leak and phosphorylation) subsystems. The external 
effectors considered included various substrates, hormones 
and inhibitors. The addition of lactate plus pyruvate and 
fatty acids results in similar effects. The Ap-producing 
subsystem is stimulated slightly more than the Ap-con- 
suming subsystem. Ca2+-acting hormones affect both the 
Ap-producing and Ap-consuming subsystems to a similar 
extent. The inhibitor, quinolinic acid, thought to be an 
inhibitor of gluconeogenesis at phosphoenolpyruvate car- 
boxykinase [20] was found to inhibit the Ap-producing 
subsystem as well as the Ap-consuming subsystem. The 
proportional activation approach is therefore a quick and 
simple way of determining the sites of action of physio- 
logical effectors uch as substrates and hormones and in 
determining the specificity of inhibitors. 
Table 1 presents briefly the results obtained in the 
present paper. The values of proportional ctivation coeffi- 
cients for different respiratory substrates, Ca2+-acting hor- 
mones and neural stimulation in muscle are shown. They 
are all close to unity. This is true especially for Ca2+-de - 
pendent systems (e.g., calcium-acting hormones and neural 
stimulation of muscle contraction) and less true for the 
substrate mediated activation of oxidative phosphorylation 
(lactate/pyruvate and fatty acids). Thus, the oxidative 
phosphorylation subsystems are activated by the external 
effectors to a similar extent. It is perhaps not surprising 
that the balance of the activation of the subsystems i
closer to unity for calcium-dependent effectors than it is 
for respiratory substrates uch as lactate/pyruvate and 
fatty acids as changes in the respiration rate caused by 
physiological changes in substrate concentrations are lower 
than those caused by changes in Ca 2÷ concentration (espe- 
cially in muscle). Calcium ion concentration seems to be a 
major physiological factor responsible for the bioenergetic 
behavior of the cell. 
The advantage of such a situation can be constant 
intermediate metabolite M concentration. Many vital reac- 
tions and processes in the cell utilize ATP, Ap or NADH, 
important intermediate metabolites in bioenergetic sys- 
tems. If concentrations of the intermediate metabolites 
were changed markedly, all these processes might be 
disturbed and internal homeostasis lost. It my be easier for 
the cell to keep the metabolite concentrations (especially 
Ap) as constant as possible rather than ensuring that each 
consuming pathway can cope with wide variations in [M]. 
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